Skip to content
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 8) * Biohaven Pharmaceutical Holding Co Ltd (NYSE: BHVN) * Celldex Therapeutics, Inc. (NASDAQ: CLDX) (announced a positive readout for the Phase 1 study of KIT inhibitor CDX-0159) * Enochian Biosciences Inc (NASDAQ: ENOB) (moved on positive outcome from a preliminary FDA meeting regarding its HIV treatment candidate that could lead to pre-IND filing) * Fennec Pharmaceuticals Inc (NASDAQ: FENC) * Kiniksa Pharmaceuticals Ltd (NASDAQ: KNSA) * Phathom Pharmaceuticals Inc (NASDAQ: PHAT) * Replimune Group Inc (NASDAQ: REPL) * Sarepta Therapeutics Inc (NASDAQ: SRPT) (announced positive results from a study of SRP-9003, its investigational gene therapy for limb-girdle muscular dystrophy Type 2E) * Y-mAbs Therapeutics, Inc (NASDAQ: YMAB) * Zynex Inc. (NASDAQ: ZYXI)None of the NYSE- or Nasdaq-listed biopharma/medical diagnostics stocks hit 52-week lows Monday.Stocks In Focus Shockwave's...
Stocks futures fell Tuesday morning, following global equities lower and pausing after a solid rally over the past several sessions....
Today is shaping up negative for Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) shareholders, with the analysts delivering......
Whilst it may not be a huge deal, we thought it was good to see that the Cellectar Biosciences, Inc. (NASDAQ:CLRB......
In this article we are going to estimate the intrinsic value of Valens GroWorks Corp. (TSE:VLNS) by taking the......
